| Rex Alan Sherer, MD | |
|
644 2nd St Ne, Suite 206, Alabaster, AL 35007-8823 | |
| (205) 620-9065 | |
| (205) 620-9051 |
| Full Name | Rex Alan Sherer |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 43 Years |
| Location | 644 2nd St Ne, Alabaster, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285608588 | NPI | - | NPPES |
| 17-10208 | Other | AL | UHC |
| 63-1132437 | Other | AL | MOST COMMERCIALS |
| 0000010125 | Other | AL | GUIDESTAR |
| 11260 | Other | AL | HEALTHSPRING |
| 63-1132437 | Other | AL | TRICARE |
| 000-4006327 | Other | AL | CIGNA |
| 510-25078 | Other | AL | BLUE CROSS OF ALABAMA |
| 529601260 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 10349 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Shelby Baptist Medical Center | Alabaster, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cahaba Valley Surgical Group, Pc | 2961304340 | 4 |
News Archive
Building on the success of innovative research by the PRISM project, the Innovative Medicine Initiative 2, a joint undertaking between the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA), has backed the program with funding for a new project to explore the underlying biology of Alzheimer's disease, schizophrenia and Major Depressive Disorder (MDD).
The National Health and Nutrition Examination Survey (NHANES) expected to be released today by the Centers for Disease Control (CDC) is on the right track with a focus on testing people's bodies for chemical contamination, say environmental health advocates working on chemical exposure issues.
A new report from the federal Agency for Healthcare Research and Quality has found that five percent of Americans are responsible for half the nation's health care spending. In the meantime, half the population spends practically nothing on health care in a year.
Novartis announced new data today showing a significant improvement in both recurrence-free survival and overall survival for patients taking Gleevec® (imatinib mesylate)* tablets for three years after surgery to remove KIT (CD117)-positive gastrointestinal stromal tumors (KIT+ GIST) compared to one year of treatment. These data will be presented at the 47th American Society of Clinical Oncology (ASCO) plenary session on Sunday, June 5.
Skin cancer is the most common cancer in the United States. While the number of cases diagnosed is on the rise, the overall survival rate has improved, but survival is uneven across the country.
› Verified 6 days ago
| Entity Name | Cahaba Valley Surgical Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902902398 PECOS PAC ID: 2961304340 Enrollment ID: O20040126000279 |
News Archive
Building on the success of innovative research by the PRISM project, the Innovative Medicine Initiative 2, a joint undertaking between the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA), has backed the program with funding for a new project to explore the underlying biology of Alzheimer's disease, schizophrenia and Major Depressive Disorder (MDD).
The National Health and Nutrition Examination Survey (NHANES) expected to be released today by the Centers for Disease Control (CDC) is on the right track with a focus on testing people's bodies for chemical contamination, say environmental health advocates working on chemical exposure issues.
A new report from the federal Agency for Healthcare Research and Quality has found that five percent of Americans are responsible for half the nation's health care spending. In the meantime, half the population spends practically nothing on health care in a year.
Novartis announced new data today showing a significant improvement in both recurrence-free survival and overall survival for patients taking Gleevec® (imatinib mesylate)* tablets for three years after surgery to remove KIT (CD117)-positive gastrointestinal stromal tumors (KIT+ GIST) compared to one year of treatment. These data will be presented at the 47th American Society of Clinical Oncology (ASCO) plenary session on Sunday, June 5.
Skin cancer is the most common cancer in the United States. While the number of cases diagnosed is on the rise, the overall survival rate has improved, but survival is uneven across the country.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rex Alan Sherer, MD 644 2nd St Ne, Suite 206, Alabaster, AL 35007-8823 Ph: (205) 620-9065 | Rex Alan Sherer, MD 644 2nd St Ne, Suite 206, Alabaster, AL 35007-8823 Ph: (205) 620-9065 |
News Archive
Building on the success of innovative research by the PRISM project, the Innovative Medicine Initiative 2, a joint undertaking between the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA), has backed the program with funding for a new project to explore the underlying biology of Alzheimer's disease, schizophrenia and Major Depressive Disorder (MDD).
The National Health and Nutrition Examination Survey (NHANES) expected to be released today by the Centers for Disease Control (CDC) is on the right track with a focus on testing people's bodies for chemical contamination, say environmental health advocates working on chemical exposure issues.
A new report from the federal Agency for Healthcare Research and Quality has found that five percent of Americans are responsible for half the nation's health care spending. In the meantime, half the population spends practically nothing on health care in a year.
Novartis announced new data today showing a significant improvement in both recurrence-free survival and overall survival for patients taking Gleevec® (imatinib mesylate)* tablets for three years after surgery to remove KIT (CD117)-positive gastrointestinal stromal tumors (KIT+ GIST) compared to one year of treatment. These data will be presented at the 47th American Society of Clinical Oncology (ASCO) plenary session on Sunday, June 5.
Skin cancer is the most common cancer in the United States. While the number of cases diagnosed is on the rise, the overall survival rate has improved, but survival is uneven across the country.
› Verified 6 days ago
Mrs. Elizabeth Allison Long Newman, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 644 2nd St Ne Ste 206, Alabaster, AL 35007 Phone: 205-620-9065 Fax: 205-620-9051 | |
Steven Taylor, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: 632 2nd St Ne, Alabaster, AL 35007 Phone: 205-664-2420 Fax: 205-621-0145 | |
William Mark Scofield, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 632 2nd St Ne, Alabaster, AL 35007 Phone: 205-621-0145 Fax: 205-664-2420 | |
Barton Smith Wood, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 636 2nd St Ne, Suite A, Alabaster, AL 35007 Phone: 205-663-1180 Fax: 205-663-1221 | |
Dr. William Charles Braswell Iii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 644 2nd St Ne, Suite 206, Alabaster, AL 35007 Phone: 205-620-9065 Fax: 205-620-9051 |